Difficulty: Medium
Average Score: 69%
Practice
Thialbendazole is rarely used now because
Correct answer
D
Rationale
The correct answer is D) It frequently produces incapacitating side effects.
Thialbendazole is rarely used now because it is known to frequently produce incapacitating side effects, such as severe gastrointestinal disturbances, headache, dizziness, and skin reactions. These side effects can significantly impact a patient's quality of life and ability to tolerate the treatment. Due to the availability of newer anthelmintic drugs with improved safety profiles, the use of thialbendazole has declined.
Option A) It is not active against roundworm and hookworm is incorrect because thialbendazole is actually effective against these parasites, but its side effect profile limits its use.
Option B) It produces lower cure rates in intestinal helminthiasis than mebendazole or albendazole is also incorrect as thialbendazole has comparable efficacy to these drugs, but its side effects make it less desirable.
Option C) It needs pretreatment fasting and post-treatment purgative is not a primary reason for the decline in thialbendazole use. While some medications may require fasting or purgatives for optimal efficacy, this is not a major factor in the decreased use of thialbendazole.
In an educational context, it is important for healthcare providers to stay updated on current treatment guidelines and drug information to provide the best care for their patients. Understanding the rationale behind the choice of medications based on efficacy, safety, and tolerability is essential in clinical practice. It is crucial to weigh the benefits and risks of each treatment option to ensure optimal patient outcomes.
Thialbendazole is rarely used now because it is known to frequently produce incapacitating side effects, such as severe gastrointestinal disturbances, headache, dizziness, and skin reactions. These side effects can significantly impact a patient's quality of life and ability to tolerate the treatment. Due to the availability of newer anthelmintic drugs with improved safety profiles, the use of thialbendazole has declined.
Option A) It is not active against roundworm and hookworm is incorrect because thialbendazole is actually effective against these parasites, but its side effect profile limits its use.
Option B) It produces lower cure rates in intestinal helminthiasis than mebendazole or albendazole is also incorrect as thialbendazole has comparable efficacy to these drugs, but its side effects make it less desirable.
Option C) It needs pretreatment fasting and post-treatment purgative is not a primary reason for the decline in thialbendazole use. While some medications may require fasting or purgatives for optimal efficacy, this is not a major factor in the decreased use of thialbendazole.
In an educational context, it is important for healthcare providers to stay updated on current treatment guidelines and drug information to provide the best care for their patients. Understanding the rationale behind the choice of medications based on efficacy, safety, and tolerability is essential in clinical practice. It is crucial to weigh the benefits and risks of each treatment option to ensure optimal patient outcomes.